These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 19709321

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. An unusual presentation of sirolimus associated cough in a renal transplant recipient.
    Adibelli Z, Dilek M, Kocak B, Tülek N, Uzun O, Akpolat T.
    Transplant Proc; 2007 Dec; 39(10):3463-4. PubMed ID: 18089408
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Potential elevation of tacrolimus trough concentrations with concomitant metronidazole therapy.
    Page RL, Klem PM, Rogers C.
    Ann Pharmacother; 2005 Jun; 39(6):1109-13. PubMed ID: 15855244
    [Abstract] [Full Text] [Related]

  • 32. Pharmacogenetics of tacrolimus and sirolimus in renal transplant patients: from retrospective analyses to prospective studies.
    Anglicheau D, Legendre C, Thervet E.
    Transplant Proc; 2007 Sep; 39(7):2142-4. PubMed ID: 17889118
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Adding sirolimus to tacrolimus-based immunosuppression in pediatric renal transplant recipients reduces tacrolimus exposure.
    Filler G, Womiloju T, Feber J, Lepage N, Christians U.
    Am J Transplant; 2005 Aug; 5(8):2005-10. PubMed ID: 15996252
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient.
    Pea F, Baccarani U, Tavio M, Cojutti P, Adani GL, Londero A, Baraldo M, Franceschi L, Furlanut M, Viale P.
    Ann Pharmacother; 2008 Nov; 42(11):1711-6. PubMed ID: 18812562
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients.
    Frassetto LA, Browne M, Cheng A, Wolfe AR, Roland ME, Stock PG, Carlson L, Benet LZ.
    Am J Transplant; 2007 Dec; 7(12):2816-20. PubMed ID: 17949460
    [Abstract] [Full Text] [Related]

  • 40. Impact of Protease Inhibitor-Based Antiretroviral Therapy on Tacrolimus Intrapatient Variability in HIV-Positive Kidney Transplant Recipients.
    Cooper M, Dunne I, Kuten S, Curtis A, Graviss EA, Nguyen DT, Hobeika M, Gaber AO.
    Transplant Proc; 2021 Apr; 53(3):984-988. PubMed ID: 33246588
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.